Prescription Drug Recall: Telmisartan-Hydrochlorothiazide Tablets Due to Defective Packaging
Glenmark Pharmaceuticals recalls 72,288 units of Telmisartan-Hydrochlorothiazide 80/25 mg tablets nationwide due to defective blister packaging that is difficult to open and causes tablets to break.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving defective blister packaging with no reported illnesses or injuries. The hazard is a packaging defect rather than contamination or allergen exposure, meeting the criteria for Moderate severity.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA has recalled 72,288 units of Telmisartan and Hydrochlorothiazide Tablets USP, 80 mg/25 mg, distributed nationwide. The recall was initiated due to complaints involving defective blister packaging that is difficult to open and causes tablets to break when the blister is opened.
The affected product lots are: Lots 17210935 and 17210936 (expiration 05/2023), Lot 17211206 (expiration 06/2023), and Lots 17211652, 17211655, and 17211658 (expiration 08/2023). The product NDC is 68462-842-13, with related package NDCs 68462-840-13 and 68462-841-13.
No illnesses or injuries have been reported in association with this recall. This is an FDA Class II recall.
The recalled product
- Product
- TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)
- Brand
- TELMISARTAN AND HYDROCHLOROTHIAZIDE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug
- Affected units
- 72,288
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lots 17210935 & 17210936.
- Exp Date 05/2023 Lot 17211206
- Exp Date 06/2023 Lots 17211652
- 17211655 & 17211658
- Exp Date 08/2023
UPCs (3)
- 0368462842133
- 0368462841136
- 0368462840139
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Glenmark Pharmaceuticals Inc., USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · TELMISARTAN AND HYDROCHLOROTHIAZIDE
- ModerateGlenmark Pharmaceuticals Recalls Telmisartan/Hydrochlorothiazide Due to Defective Blister Packs
FDA (Drugs) · 2022-08-17
Same manufacturer · Glenmark Pharmaceuticals Inc., USA
See all →- ModerateAzelaic Acid Gel 15% Recalled Over Grainy, Gritty, or Sandy Texture
FDA (Drugs) · 2026-08-05
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24
- ModerateOndansetron tablets recalled because blister packs are not fully sealed
FDA (Drugs) · 2026-01-07
- CriticalFrozen chopped methi recalled after testing positive for Salmonella
FDA (Drugs) · 2025-12-17
- ModerateBisoprolol and hydrochlorothiazide tablets recalled over traces of another drug
FDA (Drugs) · 2025-12-10
Same hazard · defective packaging
See all →- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- ModerateGabapentin Capsules 100 mg recalled for defective blister packaging
FDA (Drugs) · 2025-07-09
- ModerateMedline Hernia Repair Convenience Kit Recalls Due to Weak Seals
FDA (Devices) · 2025-04-23
- ModerateSofosbuvir and Velpatasvir Tablets Recalled for Defective Blister Pack Sealing
FDA (Drugs) · 2025-04-16
- HighNasopore Nasal Dressing Recall Due to Breached Sterile Packaging
FDA (Devices) · 2025-04-09